M. Greenleaf

A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192G.

D. Tribble, M. Maciel, M. Riddle, 2020, Vaccine.

A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge.

M. Lievens, O. Ofori-Anyinam, M. Debois, 2021, Vaccine.